Skip to content
MatchScript
Menu

Head-to-head · The Match Score

ShedRx vs Direct GLP

Both scored on the same six-factor Match Score. ShedRx wins this matchup with a 86 to 82 edge.

Higher Match Score

ShedRx

#6 · Grade B+

People who want an oral or sublingual option rather than weekly injections.

Visit ShedRx
VS

Direct GLP

#21 · Grade B−

Budget-first shoppers in a covered state who want the lowest possible price on either molecule.

Visit Direct GLP

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
84
98
Speed to Start
84
70
Formulary Match
92
80
Support Level
86
80
Flexibility
88
80
Transparency
82
80

Price, coverage & formulary

DetailShedRxDirect GLP
Semaglutide$199/mo$65/mo
Tirzepatide$299/mo$110/mo
CoverageNot disclosedWA, NM, AZ, UT, FL, DC, KS, OK, VA, GA
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjectable only
Match Score86 · B+82 · B−
Winner: ShedRx

ShedRx edges out Direct GLP, 86 to 82 on the default Match Score. A weight-focused program that also offers an oral/sublingual route for the needle-averse.

Direct GLP is still a fair pick if its strengths line up with yours — best for: Budget-first shoppers in a covered state who want the lowest possible price on either molecule.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full ShedRx reviewFull Direct GLP review

More head-to-heads

Or browse alternatives to ShedRx and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.